Investing.com - Provention Bio (NASDAQ: PRVB) reported first quarter EPS of $-0.370, $0.09 better than the analyst estimate of $-0.459. Revenue for the quarter came in at $10.77M versus the consensus estimate of $8.29M.
Provention Bio's stock price closed at $24.200. It is up 128.950% in the last 3 months and up 230.770% in the last 12 months.
Provention Bio saw #ERROR! positive EPS revisions and #ERROR! negative EPS revisions in the last 90 days. See Provention Bio's stock price’s past reactions to earnings here.
According to InvestingPro, Provention Bio's Financial Health score is "#error! performance".
Check out Provention Bio's recent earnings performance, and Provention Bio's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar